In The News, Press Releases

Feb 11, 2020

Ingredients by Nature receives patent approval for eriocitrin use in blood glucose formulations

Ingredients by Nature receives patent approval for eriocitrin use in blood glucose formulations

Montclair, California (February 11, 2020) – Ingredients by Nature (IBN), supplier of science-backed citrus-derived flavonoids and ingredients, has announced approval by the USPTO of a patent for IBN’s use of eriocitrin in its ingredient formulations, such as is found in Eriomin™.

The eriocitrin patent claim is stated as “A method of reducing blood glucose levels in a human subject in need thereof, comprising administering to the subject a composition comprising 100-200 mg eriocitrin once per day.” It will be officially issued in two to three months and published with its accompanying patent number.

“We couldn’t be happier with the progress we have made to recognize eriocitrin as a viable option for better health,” said Rob Brewster, president of IBN. “Supported by a successful first clinical trial and now this patent, our line of Eriomin lemon flavonoid blends, which are primarily comprised of eriocitrin, provide powerful support to managing healthy blood glucose levels. We look forward to revealing additional significant results from ongoing research into the effect that eriocitrin can have on blood glucose levels later this year.”

Two versions of Eriomin are currently available, Eriomin Glucose for prediabetes management and Eriomin Esport for a healthy gaming lifestyle, which help maintain blood glucose levels within the normal range.

To learn more about eriocitrin and Eriomin’s benefits, visit

About Ingredients by Nature

Ingredients by Nature™ (IBN) formulates, manufactures, and markets science-based ingredients, proprietary extracts and formula innovations for applications in dietary supplements, functional foods & beverages, cosmetics, and animal nutrition. IBN currently offers over 300 ingredient variations, including various citrus-derived ingredients, along with its custom, contract manufacturing and powder processing services. IBN recently launched two formulations of its lemon flavonoid blend Eriomin™ for prediabetes management and for a healthy gaming lifestyle. For more information, visit

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Other Posts